CG
LH icon

CFO4Life Group’s Labcorp LH Stock Holding History

CFO4Life Group’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,645
Closed -$599K – 160
2022
Q1 		$599K Buy
2,645
+60
+2% +$14.1K 0.13% 87
2021
Q4 		$698K Buy
2,585
+135
+6% +$33.4K 0.14% 77
2021
Q3 		$592K Buy
+2,450
New +$617K 0.14% 81
2018
Q4 		– Sell
-3,664
Closed -$547K – 130
2018
Q3 		$547K Buy
3,664
+240
+7% +$36.5K 0.24% 67
2018
Q2 		$528K Sell
3,424
-152
-4% -$22.9K 0.22% 70
2018
Q1 		$497K Buy
3,576
+22
+0.6% +$3.23K 0.42% 46
2017
Q4 		$487K Sell
3,554
-111
-3% -$14.7K 0.38% 45
2017
Q3 		$475K Buy
3,665
+112
+3% +$14.9K 0.38% 49
2017
Q2 		$470K Buy
3,553
+1,021
+40% +$125K 0.43% 47
2017
Q1 		$312K Buy
+2,532
New +$300K 0.28% 70

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

CFO4Life Group's LH Position: Q2 2022 in Review

CFO4Life Group sold out of Labcorp (LH) in Q2 2022, closing a stake of 2,645 shares — an estimated $599K sold.

CFO4Life Group first reported a position in LH in Q1 2017 and held it in 10 quarters. The position peaked at $698K in Q4 2021. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

  • CFO4Life Group reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
  • CFO4Life Group sold 2,645 Labcorp shares in Q2 2022, an estimated $599K.
  • CFO4Life Group first reported a position in Labcorp in Q1 2017 and held it in 10 quarters.
  • CFO4Life Group's Labcorp position peaked at $698K in Q4 2021.
  • 966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on CFO4Life Group's 13F filing for Q2 2022, filed 20 Jul 2022.